Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin

被引:268
|
作者
Cavalli, R [1 ]
Gasco, MR
Chetoni, P
Burgalassi, S
Saettone, MF
机构
[1] Univ Turin, Dipartimento Sci & Tecnol & Farm, I-10125 Turin, Italy
[2] Univ Pisa, Dipartimento Chim Bioorgan & Biofarm, I-56126 Pisa, Italy
关键词
solid lipid nanoparticles; SLN; tobramycin; rabbits; preocular retention; ocular delivery; aqueous humour bioavailability;
D O I
10.1016/S0378-5173(02)00080-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim of this study was to evaluate solid lipid nanoparticles (SLN) as carriers for topical ocular delivery of tobramycin JOB). The SLN were in the colloidal size range (average diameter below 100 nm; polydispersity index below 0.2) and contained 2.5% TOB as ion-pair complex with hexadecyl phosphate. The preocular retention of SLN in rabbit eyes was tested using drug-free, fluorescent SLN (F-SLN): these were retained for longer times on the corneal surface and in the conjunctival sac when compared with an aqueous fluorescent solution. A suspension of TOB-loaded SLN (TOB-SLN) containing 0.3% w/v TOB was administered topically to rabbits, and the aqueous humour concentration of TOB was determined up to six hours. When compared with an equal dose of TOB administered by standard commercial eyedrops, TOB-SLN produced a significantly higher TOB bioavailability in the aqueous humour. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 50 条
  • [41] Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms
    Gugleva, Viliana
    Andonova, Velichka
    PHARMACEUTICALS, 2023, 16 (03)
  • [42] Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery
    Mohanty, Biswaranjan
    Majumdar, Dipak K.
    Mishra, Sagar K.
    Panda, Amulya K.
    Patnaik, Soma
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2015, 20 (04) : 458 - 464
  • [43] Preparation, optimization, and characterization of chitosancoated solid lipid nanoparticles for ocular drug delivery
    Fengzhen Wang
    Mingwan Zhang
    Dongsheng Zhang
    Yuan Huang
    Li Chen
    Sunmin Jiang
    Kun Shi
    Rui Li
    The Journal of Biomedical Research, 2018, 32 (06) : 411 - 423
  • [44] Solid lipid nanoparticles (SLN) for controlled drug delivery II. drug incorporation and physicochemical characterization
    Schwarz, C
    Mehnert, W
    JOURNAL OF MICROENCAPSULATION, 1999, 16 (02) : 205 - 213
  • [45] Characterization and body distribution of β-elemene solid lipid nanoparticles (SLN)
    Wang, YZ
    Deng, YH
    Mao, SR
    Jin, SX
    Wang, J
    Bi, DZ
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (08) : 769 - 778
  • [46] Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)
    Andonova, Velichka
    Peneva, Petya
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (43) : 6630 - 6642
  • [47] Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and raman spectroscopy
    Jores, K
    Haberland, A
    Wartewig, S
    Mäder, K
    Mehnert, W
    PHARMACEUTICAL RESEARCH, 2005, 22 (11) : 1887 - 1897
  • [48] Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy
    Katja Jores
    Annekathrin Haberland
    Siegfried Wartewig
    Karsten Mäder
    Wolfgang Mehnert
    Pharmaceutical Research, 2005, 22 : 1887 - 1897
  • [49] Development of Contact Lenses Loaded Thiolated Nanoparticles for Ocular Delivery of Tobramycin
    Saleem, Wajiha
    Akhtar, Sohail
    Jahan, Faryal
    Ashraf, Sidra
    Shahnaz, Gul
    Rahdar, Abbas
    Pandey, Sadanand
    BIONANOSCIENCE, 2024, 14 (03) : 2665 - 2677
  • [50] Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats.: Part II -: Tissue distribution
    Bargoni, A
    Cavalli, R
    Zara, GP
    Fundarò, A
    Caputo, O
    Gasco, MR
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 497 - 502